In person
ZoBio is pleased to attend the RSC-BMCS Fragment-Based Drug Discovery meeting in Cambridge this September.
The meeting brings together scientists from across academia, biotechnology, and the pharmaceutical industry to discuss advances and impactful applications of fragment-based drug discovery.
ZoBio will be represented by Johan Veerman, Head of Chemistry, who will also present a poster entitled:
Site-selective screening: Design, synthesis and application of stable S-adenosylmethionine-based probes for fragment screening against METTL3/14
We look forward to sharing our work, exchanging ideas with the fragment-based drug discovery community, and connecting with fellow scientists in Cambridge.